FDA Inspection
Danville Regional Medical Center/Blood BankDanville Regional Medical Center/Blood Bank – FDA Inspection, Aug 11, 2017
Record Details
This FDA Inspection record concerns Danville Regional Medical Center/Blood Bank, with an inspection on August 11, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 11, 2017
- Product Type
- Biologics
View Company Profile
ID · 368d2ff2-38c9-4983-80e2-0fa13c06aca3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1024833
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Danville Regional Medical Center/Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2025 | Not classified | Baltimore District Office | |
| August 1, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 2, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 3, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 11, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Danville Regional Medical Center/Blood Bank
- FDA Inspection 1277038 - 2025-06-24
- FDA Inspection 1211661 - 2023-08-01
- FDA Inspection 1091060 - 2019-05-02
- FDA Inspection 869590 - 2014-03-03
- FDA Inspection 785129 - 2012-05-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.